Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit
PUBT · 05/27 12:03
Share
Listen to the news
- Coya Therapeutics will present the ALSTARS Phase 2 trial design for COYA 302 at the 5th ALS Drug Development Summit in Boston, June 2-4, 2026.
- A poster session is scheduled for June 3, 2026 at 4:45 p.m. ET.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605270800BIZWIRE_USPR_____20260527_BW446509) on May 27, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending